Cowen Upgrades Myriad Genetics (MYGN) to Outperform
Tweet Send to a FriendGet Alerts MYGN Hot Sheet
Price: $26.44 -0.68%
Rating Summary:
8 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Rating Summary:
8 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Trade MYGN Now!
Cowen upgraded Myriad Genetics (NASDAQ: MYGN) from Neutral to Outperform.
For an analyst ratings summary and ratings history on Myriad Genetics click here. For more ratings news on Myriad Genetics click here.
Shares of Myriad Genetics closed at $24.41 yesterday, with a 52 week range of $17.51-$25.89.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Myriad Genetics click here. For more ratings news on Myriad Genetics click here.
Shares of Myriad Genetics closed at $24.41 yesterday, with a 52 week range of $17.51-$25.89.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Goldman Sachs Upgrades Enbridge (ENB) to Conviction Buy
- Raymond James Upgrades FLIR Systems, Inc. (FLIR) to Strong Buy
- JPMorgan Upgrades Hornbeck Offshore (HOS) to Overweight
Create E-mail Alert Related Categories
UpgradesRelated Entities
Cowen & CoLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

